AstraZeneca’s Tezspire receives approval for asthma treatment
Green light for new asthma pen which offers self-administration option across the EU
Read More
Tag: self-administration
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
